Outcome of Solifenacin Monotherapy and Combined Solifenacin and Mirabegron Therapy in Patient With Overactive Bladder. J. Com. Med. Col. Teachers Asso. 2024, 28 (2), 75-81. https://doi.org/10.3329/jcomcta.v28i2.78017.